ACRX Historical Earnings image   This ACRX historical earnings page last updated 8/15/2022
ACRX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/11/20220.00B
Q1 20225/16/20220.00B
Q4 20213/10/20220.00M
Q3 202111/15/20210.00B
Q2 20218/16/20210.00B
Q1 20215/17/20210.00B
Q4 20203/15/20210.00B
Q3 202011/5/20200.00B
Q2 20208/10/20200.00B
Q1 20205/11/20200.00B
Q4 20193/16/20200.00B
Q3 201911/6/20190.00B
Q2 20198/5/20190.00B
Q1 20195/8/20190.00B
Q4 20183/7/2019613000
Q3 201811/2/2018377000
Q2 20188/2/2018818000
Q1 20185/9/2018343000
Q4 20173/8/2018740000
Q3 201711/9/20171.49M
Q2 20178/1/20172.66M
Q1 20175/8/20173.11M
Q4 20163/2/20176.43M
Q3 201611/1/20163.37M
Q2 20167/28/20164.53M
Q1 20165/2/20163.02M
Q4 20153/7/20161.73M
Q3 201510/29/201515.43M
Q2 20158/3/20151.92M
Q1 20155/4/2015181000
Q4 20143/9/2015226000
Q3 201411/10/20144.83M
Q2 20148/11/201471000
Q1 20145/8/2014100000
Q4 20133/3/201427.60M
Q3 201311/5/2013548000
Q2 20138/12/2013407000
Q1 20135/8/2013940000
Q4 20123/12/20131.70M
Q3 201211/6/2012166000
ACRX Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20228/11/2022-0.060
Q1 20225/16/2022-0.060
Q4 20213/10/2022-0.060
Q3 202111/15/2021-0.070
Q2 20218/16/2021-0.080
Q1 20215/17/2021-0.080
Q4 20203/15/2021-0.100
Q3 202011/5/2020-0.100
Q2 20208/10/2020-0.080
Q1 20205/11/2020-0.200
Q4 20193/16/2020-0.180
Q3 201911/6/2019-0.160
Q2 20198/5/2019-0.160
Q1 20195/8/2019-0.170
Q4 20183/7/2019-0.18
Q3 201811/2/2018-0.21
Q2 20188/2/2018-0.2
Q1 20185/9/2018-0.23
Q4 20173/8/2018-0.2
Q3 201711/9/2017-0.28
Q2 20178/1/2017-0.29
Q1 20175/8/2017-0.34
Q4 20163/2/2017-0.21
Q3 201611/1/2016-0.25
Q2 20167/28/2016-0.24
Q1 20165/2/2016-0.25
Q4 20153/7/2016-0.24
Q3 201510/29/20150.11
Q2 20158/3/2015-0.2
Q1 20155/4/2015-0.27
Q4 20143/9/2015-0.32
Q3 201411/10/2014-0.13
Q2 20148/11/2014-0.3
Q1 20145/8/2014-0.22
Q4 20133/3/2014-0.18
Q3 201311/5/2013-0.26
Q2 20138/12/2013-0.22
Q1 20135/8/2013-0.34
Q4 20123/12/2013-0.41
Q3 201211/6/2012-0.38
Quotes delayed 20 minutes

Email EnvelopeFree ACRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
AcelRx Pharmaceuticals (ACRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ACXP Historical Earnings
ADGI Historical Earnings
ADIL Historical Earnings
ADMA Historical Earnings
ADMP Historical Earnings
ADMS Historical Earnings
ADPT Historical Earnings
ADTX Historical Earnings
ADUS Historical Earnings
ADVM Historical Earnings
What was the record high ACRX historical earnings result?
In terms of earnings or revenue, what is the best ACRX historical earnings result that AcelRx Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ACRX historical earnings result was set in Q3 2015, when AcelRx Pharmaceuticals posted results of 0.11/share. The most successful revenue quarter within our data set was Q4 2013 when AcelRx Pharmaceuticals reported revenue of 27.60M.

What was the lowest AcelRx Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ACRX has reported, and when?

✔️Accepted answer: Within our data set, the lowest ACRX historical earnings result was set in Q4 2012, when AcelRx Pharmaceuticals posted results of -0.41/share. The smallest revenue quarter within our data set was Q4 2021 when AcelRx Pharmaceuticals reported revenue of 0.00M.

On this page we presented the ACRX historical earnings date information for AcelRx Pharmaceuticals. Reviewing that ACRX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2015, when ACRX posted adjusted EPS of 0.11/share. Meanwhile the lowest ACRX historical earnings result was in Q4 2012, when ACRX posted adjusted EPS of -0.41/share. Moving to AcelRx Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2013 when ACRX reported 27.60M in revenue, while the smallest revenue quarter was Q4 2021 when ACRX reported 0.00M in revenue.

For self directed investors doing their due diligence on ACRX or any other given stock, their research can benefit from looking into all of the AcelRx Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into AcelRx Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ACRX. Thanks for visiting, and the next time you need to research ACRX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Institutional Holders of SYNH, SONA YTD Return, MEAC Average Annual Return.

 

ACRX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.